SpinChip Diagnostics ASA

Carnegie Investment Bank is proud to have acted as Joint Bookrunner in connection with SpinChip Diagnostics ASA’ successful NOK 43 million convertible loan issue.

SpinChip Diagnostics is a medical device company who has developed a proprietary platform focused on in vitro diagnostics (IVD) to develop diagnostic tests for acute and chronic cardiac indications where test results are rapidly needed to provide patients with life-saving treatments.

Carnegie congratulates Chair Åse Aulie Michelet, CEO Morten Jurs, CSO Stig Morten Borch, CFO Hamed Brodersen, the shareholders and the rest of the SpinChip team with the successful transaction. We look forward to continuing our support of SpinChip going forward.

Related articles

KMC Properties
Investment Banking

KMC Properties

KMC Properties ASA and Logistea to combine and form a leading Nordic logistics, warehouse and...

Nel & Cavendish Hydrogen
Investment Banking

Nel & Cavendish Hydrogen

Spin-off of Nel Hydrogen’s Fueling division into Cavendish Hydrogen and subsequent listing on the Oslo...

Schibsted
Investment Banking

Schibsted

Completed sale of Schibsted’s news media operations – NOK 6.3 billion Carnegie Investment Bank is...